InSphero raises €24.2M Series D round
31 March 2023· Schlieren, Switzerland· biotechnology, drug_discovery, 3d_cell_culture, in_vitro_testing, b2b, software_hardware
To commercialize its cryo-preservation technology to enable further growth and scalability, and advance the adoption of 3D microtissues in research and drug development.
Investors
LeadZEISS Ventures
About InSphero
Stage
Series D
Headquarters
Schlieren, Switzerland
Founded
2009
Team Size
51–200
Sectors
biotechnologydrug_discovery3d_cell_culturein_vitro_testingb2bsoftware_hardware
Source: https://www.zeiss.com/corporate/newsroom/press-releases/2023/zeiss-ventures-invests-in-insphero.html